How to ‘ACE’ geographical expansion in Europe
Forging the links across the value chain
Biotech companies are now at the forefront of innovation in the search for new cures and hope for patients – they are responsible for ~70% of global clinical trials (of which 42% are in partnership) and for the development of nearly half of 2018 FDA approved medicines.
Shaping the future of UK healthcare
Patient access to innovative medicine in Europe
The future of real-world evidence
Biopharma is placing greater emphasis on real-world evidence (RWE), a Deloitte life-sciences survey finds. RWE helps leaders show value for access, understand the patient journey, and provide more data.
Future of life sciences regulation: How industry, regulators and patients can succeed together
Embracing the future of work to unlock R&D productivity
The future awakens